All entries for: Passage Bio

January 10, 2025

Passage Bio

Layoffs

Philadelphia, PA
51-200 employees

This transition, coupled with an associated reduction in workforce of approximately 55% and reductions in operating expenses, is expected to extend cash runway into the first quarter of 2027.

Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
Scroll to Top